PUBLIC COMPANY
saveIpsen SA
updated 1mo ago
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales.
community read0 votes
pipeline
5
marketed
2
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(5)
pipeline depth5 products
1Phase 11Phase 22Marketed1Unknown
Marketed
elafibranor
Primary Sclerosing Cholangitis
Peroxisome proliferator-activated receptor alphaPeroxisome proliferator-activated receptor delta
Marketedodevixibat
Biliary Atresia
Ileal sodium/bile acid cotransporter
Phase 2irinotecan hydrochloride
Human Epidermal Growth Factor Receptor 2 Negative Breast…
DNA topoisomerase 1
Phase 1Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that